Sort
85,873 grants matching “alzheimers”
A Multi-Site Cluster RCT of the Dementia Symptom Management At Home Program
$745,334Abraham Aizer Brody · New York University · R01 · FY2019 · AG
A Novel Small molecule TNF-alpha inhibitor as a disease-modifying AD drug treatment.
$745,321Somasundar Prasad Gabbita · P2d, Inc. · R44 · FY2015 · AG
Synaptic Resilience to Psychosis in Alzheimer Disease
$745,305Robert A Sweet · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · MH
Drosophila Genomics Resource Center
$745,238Justen R Andrews · Trustees Of Indiana University · P40 · FY2009 · RR
Midlife cognitive aging in Hispanic/Latinos: Predictors and mechanisms of decline
$745,204Angelina R Sutin · Florida State University · U01 · FY2020 · AG
Glutamate receptors and human neurological disease
$745,173Stephen F. Traynelis · Emory University · R35 · FY2020 · NS
Target Engagement Biomarkers for Alzheimer's Therapeutics
$745,159Susan M Catalano · Cognition Therapeutics, Inc. · R44 · FY2017 · AG
Genetic Modifiers of TREM2 in Alzheimer's Disease
$745,139Carlos Cruchaga · Washington University · R01 · FY2025 · AG
Regulation of NF-Kappa B
$745,119Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2010 · AI
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease
$745,104Yakeel T. Quiroz · Massachusetts General Hospital · R01 · FY2020 · AG
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease
$745,104Yakeel T. Quiroz · Massachusetts General Hospital · R01 · FY2018 · AG
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease
$745,104Yakeel T. Quiroz · Massachusetts General Hospital · R01 · FY2021 · AG
Relationship between tau pathology and cognitive impairment in autosomal dominant Alzheimer's disease
$745,104Yakeel T. Quiroz · Massachusetts General Hospital · R01 · FY2019 · AG
Midwest Roybal Center for Health Promotion and Translation
$745,100David X Marquez · University Of Illinois At Chicago · P30 · FY2023 · AG
HIGHLY EFFICIENT CEREBRAL PERFUSION MRI
$745,093David Alan Feinberg · Advanced Mri Technology, Llc · R44 · FY2015 · NS
Epitranscriptomic Mechanism in pathogenesis of Alzheimerâs disease
$745,092Lulu Jiang · University Of Virginia · R01 · FY2025 · AG
Elucidating changes in astrocyte subpopulations associated with resistance to Alzheimers Disease pathology in multi-ethnic cohorts
$745,084Vilas Menon · Columbia University Health Sciences · R01 · FY2022 · AG
Microstructural changes in gray and white matter in aging and AD
$745,073Hadi Hosseini · Stanford University · R01 · FY2024 · AG
Glutamate receptors and human neurological disease
$745,051Stephen F. Traynelis · Emory University · R35 · FY2024 · NS
Religious Orders Study Core
$745,050David A Bennett · Rush University Medical Center · P30 · FY2014 · AG
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
$744,989Sascha Dublin · Kaiser Foundation Research Institute · R01 · FY2023 · AG
Clinical Core
$744,977Eric M Reiman · Banner Sun Health Research Institute · P30 · FY2011 · AG
ApoE isoform-specific structure: Insights on biology and pathobiology
$744,945Andrea Soranno · Mayo Clinic Jacksonville · U19 · FY2025 · AG
Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease
$744,923Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AG
Brain networks in mouse models of aging
$744,876Alexandra Badea · Duke University · R01 · FY2022 · AG